We validated the expression of the top 10 genes from the negative and positive selections in our previously established bortezomib-resistant MM cells and identified HRP2 as the most differentially expressed one among the enriched genes (Supplemental Figure 1B). Here, HDGFL2 is linked to Miyoshi myopathy.